Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 9/2010

01-09-2010 | Correspondence

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices

Authors: Antoine G. Schneider, Marie-Hélène Perez, Piergiorgio Tozzi, Pierre Voirol, Patrick Schoettker, Anne Angelillo-Scherrer, Jacques Cotting, Ludwig Von Segesser, Philippe Eggimann

Published in: Intensive Care Medicine | Issue 9/2010

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM (2008) Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 118:331–338CrossRefPubMed
2.
Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73–92CrossRefPubMed
3.
Veldman A, Neuhaeuser C, Akintuerk H, Thul J, Gehron J, Schranz D, Michel-Behnke I (2007) rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 17:1176–1181CrossRefPubMed
4.
Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB (2007) Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg 84:161–168CrossRefPubMed
5.
Gandhi MJ, Pierce RA, Zhang L, Moon MR, Despotis GJ, Moazami N (2007) Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg 2:32CrossRefPubMed
Metadata
Title
Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices
Authors
Antoine G. Schneider
Marie-Hélène Perez
Piergiorgio Tozzi
Pierre Voirol
Patrick Schoettker
Anne Angelillo-Scherrer
Jacques Cotting
Ludwig Von Segesser
Philippe Eggimann
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 9/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-1937-y

Other articles of this Issue 9/2010

Intensive Care Medicine 9/2010 Go to the issue

Original

Implementing glucose control in intensive care: a multicenter trial using statistical process control

Brief Report

Continuous positive airway pressure ventilation with helmet in infants under 1 year

Erratum

Erratum to: Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia

Correspondence

Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study

Experimental

Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats

Pediatric Original

Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation